Cargando…
GK1: An Alternative Treatment to Control the Respiratory Complications During COVID19
Autores principales: | Fragoso, Gladis, Sciutto, Edda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IMSS. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605854/ https://www.ncbi.nlm.nih.gov/pubmed/33168195 http://dx.doi.org/10.1016/j.arcmed.2020.10.019 |
Ejemplares similares
-
Neuroinflammation in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection: Pathogenesis and clinical manifestations
por: Cárdenas, Graciela, et al.
Publicado: (2022) -
GK-1 Induces Oxidative Stress, Mitochondrial Dysfunction, Decreased Membrane Potential, and Impaired Autophagy Flux in a Mouse Model of Breast Cancer
por: Cruz-Gregorio, Alfredo, et al.
Publicado: (2022) -
GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental model
por: Hernández-Aceves, Juan A., et al.
Publicado: (2023) -
Mechanisms Underlying the Induction of Regulatory T cells and Its Relevance in the Adaptive Immune Response in Parasitic Infections
por: Adalid-Peralta, Laura, et al.
Publicado: (2011) -
Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis?
por: Toledo, Andrea, et al.
Publicado: (2023)